+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Veterinary Antibiotics Market - Global Forecast 2026-2032- Product Image
Veterinary Antibiotics Market - Global Forecast 2026-2032- Product Image
Sale

Veterinary Antibiotics Market - Global Forecast 2026-2032

  • Report

  • 184 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6021513
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Veterinary Antibiotics Market is projected to reach USD 5.59 Billion in 2026. It is expected to continue growing at a CAGR of 5.76%, reaching USD 7.88 Billion by 2032.

Veterinary Antibiotics: Executive Summary and Strategic Context

Veterinary antibiotics are essential for treating bacterial disease, protecting animal welfare, and supporting food-animal health. The sector is being reshaped by antimicrobial-resistance concerns, tighter stewardship expectations, changing production systems, and stronger requirements for traceability and responsible use. Demand is therefore increasingly influenced by disease prevention, veterinary oversight, diagnostic capability, residue control, and access to alternatives-not solely by animal population or treatment volume.

Stewardship, Surveillance, and Prevention Are Reshaping the Market

The landscape is shifting from routine or precautionary use toward diagnosis-led treatment, narrower-spectrum selection, accurate dosing, and documented withdrawal compliance. Regulators and food producers are emphasizing antimicrobial stewardship, while surveillance programs are improving visibility into resistance patterns and medicine consumption. Vaccination, biosecurity, improved husbandry, rapid diagnostics, and infection-prevention protocols are becoming increasingly important complements to antibiotics. These changes favor suppliers and service models that support responsible use, product quality, regulatory compliance, and measurable animal-health outcomes.

Artificial Intelligence Strengthens Diagnostics, Monitoring, and Stewardship

Artificial intelligence can improve veterinary antibiotic stewardship by identifying disease signals from clinical records, laboratory results, animal behavior, production data, and environmental conditions. Predictive tools may help prioritize diagnostic testing, detect abnormal morbidity earlier, and support treatment decisions when combined with qualified veterinary judgment. AI can also assist pharmacovigilance, resistance surveillance, inventory management, and documentation. Its value depends on representative data, validation across species and production systems, explainability, cybersecurity, and clear accountability; it should augment rather than replace professional diagnosis and prescribing decisions.

Regional Insights: Regulation and Production Systems Create Distinct Priorities

North America combines advanced veterinary oversight, established surveillance, and sophisticated livestock and companion-animal services, with continued emphasis on stewardship and traceability. Latin America’s large food-animal base makes disease prevention, access to veterinary expertise, and responsible use important priorities, while regulatory consistency varies across markets. Europe places particularly strong emphasis on antimicrobial-resistance reduction, prescription controls, residue management, and integrated One Health surveillance. The Middle East is shaped by import dependence, climate stress, and concentrated production systems, increasing the importance of biosecurity and reliable supply. Africa faces uneven access to diagnostics, veterinary services, and quality-assured medicines, making capacity building central to stewardship. Asia-Pacific combines diverse regulatory environments with major aquaculture, poultry, swine, and companion-animal sectors, creating strong demand for scalable prevention, surveillance, and responsible-use programs.

Group Insights: Cooperation Determines Stewardship and Access

ASEAN markets differ in regulatory maturity and animal-production structure, so regional alignment, laboratory capacity, and harmonized quality standards can improve responsible access. BRICS economies encompass substantial livestock, aquaculture, pharmaceutical, and research capabilities, while also facing varied resistance and enforcement challenges; cooperation on surveillance and veterinary infrastructure is consequential. The European Union maintains a highly coordinated policy environment centered on prudent use, monitoring, and food-chain safeguards. G7 members generally have advanced regulatory systems and research capacity, but must address complex companion-animal demand and global supply-chain dependencies. GCC countries prioritize food security, import resilience, and biosecurity under arid conditions. NATO members span diverse animal-health systems, making interoperability, emergency preparedness, and secure medical supply chains relevant to veterinary resilience.

Country Insights: National Systems Shape Adoption and Stewardship

Australia’s extensive livestock systems make biosecurity, remote service delivery, and resistance monitoring important. Brazil’s major agricultural base heightens the value of prevention, diagnostics, and export-aligned residue controls. Canada and the United States emphasize veterinary oversight, surveillance, and production efficiency across large and diverse animal-health systems. China and India combine substantial livestock populations with varied regional access to diagnostics, regulation, and veterinary services. Japan and South Korea have advanced food-safety and biosecurity expectations, alongside significant companion-animal demand. France, Germany, Italy, and Spain operate within European stewardship and residue-control frameworks while addressing production-specific needs. The United Kingdom continues to prioritize prudent prescribing, monitoring, and veterinary accountability. Mexico’s mixed production systems create demand for accessible diagnostics, quality assurance, and stronger stewardship implementation. Russia’s extensive geography and supply-chain considerations make availability, disease surveillance, and veterinary infrastructure important strategic issues.

Leadership Priorities for Responsible Growth and Resilience

Industry leaders should make diagnosis-led treatment and antimicrobial stewardship central to product, service, and customer strategies. Investments should target rapid diagnostics, resistance surveillance, vaccination, biosecurity, digital treatment records, and veterinary education. Portfolio planning should account for species-specific needs, regulatory requirements, withdrawal periods, and quality assurance. Organizations should establish measurable indicators covering appropriate use, adverse events, treatment outcomes, residue compliance, and supply continuity. Partnerships with regulators, laboratories, producers, veterinarians, and public-health stakeholders can improve adoption and trust. AI initiatives should begin with clearly governed use cases, validated datasets, human oversight, and transparent performance monitoring.

Research Methodology: Evidence-Led Market Interpretation

This executive summary uses the supplied market scope for veterinary antibiotics and synthesizes established industry themes from authoritative categories of evidence, including veterinary-medicine regulation, antimicrobial-resistance surveillance, One Health guidance, food-safety requirements, peer-reviewed research, and publicly available national and regional policy materials. Findings are organized across the requested regions, economic and political groupings, and countries. The assessment is qualitative and strategic: it does not provide market estimates, market shares, forecasts, or company-level comparisons. Interpretations should be refreshed as regulations, resistance patterns, treatment guidelines, and production practices evolve.

Conclusion: Stewardship and Prevention Define the Next Phase

Veterinary antibiotics will remain important for treating bacterial disease, but their role is increasingly governed by stewardship, evidence, and prevention. The strongest strategic position comes from combining quality-assured medicines with diagnostics, biosecurity, vaccination, surveillance, digital records, and accountable veterinary decision-making. Regional and national differences require locally adapted implementation, while international cooperation is essential for resistance control and supply resilience. Leaders that demonstrate responsible use and measurable animal-health outcomes will be better placed to support welfare, food safety, and One Health objectives.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Veterinary Antibiotics Market, by Class
7.1. Introduction
7.2. Aminoglycosides
7.2.1. Amikacin
7.2.2. Apramycin
7.2.3. Gentamicin
7.2.4. Kanamycin
7.2.5. Neomycin
7.3. Amphenicols
7.3.1. Azidamfenicol
7.3.2. Chloramphenicol
7.3.3. Florfenicol
7.3.4. Metiamycin
7.3.5. Thiamphenicol
7.4. Cephalosporins
7.4.1. Cefalexin
7.4.2. Cefalonium
7.4.3. Cefazolin
7.4.4. Cefovecin
7.4.5. Ceftiofur
7.4.6. Ceftriaxone
7.5. Fluoroquinolones
7.5.1. Danofloxacin
7.5.2. Difloxacin
7.5.3. Enrofloxacin
7.5.4. Norfloxacin
7.5.5. Orbifloxacin
7.6. Macrolides
7.6.1. Azithromycin
7.6.2. Clarithromycin
7.6.3. Erythromycin
7.6.4. Gamithromycin
7.6.5. Spiramycin
7.6.6. Tilmicosin
7.6.7. Tulathromycin
7.6.8. Tylosin
7.7. Other Quinolones
7.7.1. Cinoxacin
7.7.2. Nalidixic Acid
7.7.3. Oxolinic Acid
7.7.4. Pipemidic Acid
7.7.5. Rosoxacin
7.8. Penicillins
7.8.1. Amoxicillin
7.8.2. Ampicillin
7.8.3. Cloxacillin
7.8.4. Oxacillin
7.8.5. Penicillin G
7.8.6. Penicillin V
7.9. Polymixins
7.9.1. Colistin/Polymyxin E
7.9.2. Polymyxin B
7.10. Sulfonamides
7.10.1. Sulfadiazine
7.10.2. Sulfamerazine
7.10.3. Sulfamethizole
7.10.4. Sulfamethoxazole
7.10.5. Sulfasalazine
7.11. Tetracyclines
7.11.1. Chlortetracycline
7.11.2. Doxycycline
7.11.3. Oxytetracycline
7.11.4. Tetracycline
7.12. Trimethoprim
7.12.1. Trimethoprim Plus Sulfamethazine
7.12.2. Trimethoprim-Sulfadiazine
7.12.3. Trimethoprim-Sulfadimidine
7.12.4. Trimethoprim-Sulfadoxine
7.12.5. Trimethoprim-Sulfamethoxazole (TMP-SMX)
8. Veterinary Antibiotics Market, by Animal Type
8.1. Introduction
8.2. Companion Animals
8.2.1. Cats
8.2.2. Dogs
8.3. Livestock
8.3.1. Cattle
8.3.2. Poultry
8.3.3. Sheep & Goats
8.3.4. Swine
9. Veterinary Antibiotics Market, by End-User
9.1. Introduction
9.2. Animal Production Facilities
9.3. Household Pet Owners
9.4. Veterinary Clinics
10. Veterinary Antibiotics Market, by Therapeutic Areas
10.1. Introduction
10.2. Dermatological Infections
10.3. Gastrointestinal Infections
10.4. Reproductive System Infections
10.5. Respiratory Infections
10.6. Soft Tissue & Wound Infections
10.7. Systemic Infections
10.8. Urinary Tract Infections
11. Veterinary Antibiotics Market, by Region
11.1. Introduction
11.2. Asia-Pacific
11.3. North America
11.4. Latin America
11.5. Europe
11.6. Middle East
11.7. Africa
12. Veterinary Antibiotics Market, by Group
12.1. Introduction
12.2. ASEAN
12.3. GCC
12.4. European Union
12.5. BRICS
12.6. G7
12.7. NATO
13. Veterinary Antibiotics Market, by Country
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. United Kingdom
13.7. Germany
13.8. France
13.9. Russia
13.10. Italy
13.11. Spain
13.12. China
13.13. India
13.14. Japan
13.15. Australia
13.16. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. Market Concentration Analysis, 2025
14.2.1. Concentration Ratio (CR)
14.2.2. Herfindahl Hirschman Index (HHI)
14.3. Recent Developments & Impact Analysis, 2025
14.4. Product Portfolio Analysis, 2025
14.5. Benchmarking Analysis, 2025
15. Company Profiles
15.1. Ashish Life Science Private Limited
15.2. Bimeda Inc.
15.3. Biogénesis Bagó S.A.
15.4. C.H. Boehringer Sohn AG & Co. KG
15.5. Ceva Santé Animale
15.6. Dechra Pharmaceuticals PLC
15.7. Eco Animal Health Group PLC
15.8. Elanco Animal Health Incorporated
15.9. Intas Pharmaceuticals Ltd.
15.10. Krka, d. d., Novo mesto
15.11. Kyoritsuseiyaku Corporation
15.12. LABORATORIO AVI-MEX
15.13. LABORATORIOS CALIER, S.A.
15.14. Merck KGaA
15.15. Neogen Corporation
15.16. Ourofino Group
15.17. Sequent Scientific Ltd.
15.18. Vetoquinol SA
15.19. Virbac SA
15.20. Zoetis Inc.
16. Key Experts
LIST OF FIGURES
FIGURE 1. Global Veterinary Antibiotics Market, Years Considered for the Study
FIGURE 2. Global Veterinary Antibiotics Market, Research Design
FIGURE 3. Global Veterinary Antibiotics Market, Research Framework
FIGURE 4. Global Veterinary Antibiotics Market, Data Triangulation
FIGURE 5. Global Veterinary Antibiotics Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Veterinary Antibiotics Market Size, by Class, 2025 vs 2032 (%)
FIGURE 7. Global Veterinary Antibiotics Market Size, by Class, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Veterinary Antibiotics Market Size, by Animal Type, 2025 vs 2032 (%)
FIGURE 9. Global Veterinary Antibiotics Market Size, by Animal Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Veterinary Antibiotics Market Size, by End-User, 2025 vs 2032 (%)
FIGURE 11. Global Veterinary Antibiotics Market Size, by End-User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Veterinary Antibiotics Market Size, by Therapeutic Areas, 2025 vs 2032 (%)
FIGURE 13. Global Veterinary Antibiotics Market Size, by Therapeutic Areas, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Veterinary Antibiotics Market Size, by Region, 2025 vs 2032 (%)
FIGURE 15. Global Veterinary Antibiotics Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Veterinary Antibiotics Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global Veterinary Antibiotics Market Size, by Country, 2025 vs 2032 (%)
FIGURE 18. Global Veterinary Antibiotics Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Veterinary Antibiotics Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Veterinary Antibiotics Market Segmentation & Coverage
TABLE 2. Global Veterinary Antibiotics Market Size, 2017-2032 (USD Million)
TABLE 3. Global Veterinary Antibiotics Market Size, by Class, 2017-2032 (USD Million)
TABLE 4. Global Aminoglycosides Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Aminoglycosides Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Aminoglycosides Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Amikacin Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Amikacin Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Amikacin Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Apramycin Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Apramycin Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Apramycin Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Gentamicin Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Gentamicin Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Gentamicin Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Kanamycin Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Kanamycin Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Kanamycin Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Neomycin Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Neomycin Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Neomycin Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Amphenicols Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Amphenicols Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Amphenicols Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Azidamfenicol Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Azidamfenicol Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Azidamfenicol Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Chloramphenicol Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Chloramphenicol Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Chloramphenicol Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Florfenicol Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Florfenicol Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Florfenicol Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Metiamycin Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Metiamycin Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Metiamycin Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Thiamphenicol Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Thiamphenicol Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Thiamphenicol Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Cephalosporins Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Cephalosporins Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Cephalosporins Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Cefalexin Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Cefalexin Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Cefalexin Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Cefalonium Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Cefalonium Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Cefalonium Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Cefazolin Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Cefazolin Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Cefazolin Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Cefovecin Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Cefovecin Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Cefovecin Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Ceftiofur Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Global Ceftiofur Market Size, by Group, 2017-2032 (USD Million)
TABLE 57. Global Ceftiofur Market Size, by Country, 2017-2032 (USD Million)
TABLE 58. Global Ceftriaxone Market Size, by Region, 2017-2032 (USD Million)
TABLE 59. Global Ceftriaxone Market Size, by Group, 2017-2032 (USD Million)
TABLE 60. Global Ceftriaxone Market Size, by Country, 2017-2032 (USD Million)
TABLE 61. Global Fluoroquinolones Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. Global Fluoroquinolones Market Size, by Group, 2017-2032 (USD Million)
TABLE 63. Global Fluoroquinolones Market Size, by Country, 2017-2032 (USD Million)
TABLE 64. Global Danofloxacin Market Size, by Region, 2017-2032 (USD Million)
TABLE 65. Global Danofloxacin Market Size, by Group, 2017-2032 (USD Million)
TABLE 66. Global Danofloxacin Market Size, by Country, 2017-2032 (USD Million)
TABLE 67. Global Difloxacin Market Size, by Region, 2017-2032 (USD Million)
TABLE 68. Global Difloxacin Market Size, by Group, 2017-2032 (USD Million)
TABLE 69. Global Difloxacin Market Size, by Country, 2017-2032 (USD Million)
TABLE 70. Global Enrofloxacin Market Size, by Region, 2017-2032 (USD Million)
TABLE 71. Global Enrofloxacin Market Size, by Group, 2017-2032 (USD Million)
TABLE 72. Global Enrofloxacin Market Size, by Country, 2017-2032 (USD Million)
TABLE 73. Global Norfloxacin Market Size, by Region, 2017-2032 (USD Million)
TABLE 74. Global Norfloxacin Market Size, by Group, 2017-2032 (USD Million)
TABLE 75. Global Norfloxacin Market Size, by Country, 2017-2032 (USD Million)
TABLE 76. Global Orbifloxacin Market Size, by Region, 2017-2032 (USD Million)
TABLE 77. Global Orbifloxacin Market Size, by Group, 2017-2032 (USD Million)
TABLE 78. Global Orbifloxacin Market Size, by Country, 2017-2032 (USD Million)
TABLE 79. Global Macrolides Market Size, by Region, 2017-2032 (USD Million)
TABLE 80. Global Macrolides Market Size, by Group, 2017-2032 (USD Million)
TABLE 81. Global Macrolides Market Size, by Country, 2017-2032 (USD Million)
TABLE 82. Global Azithromycin Market Size, by Region, 2017-2032 (USD Million)
TABLE 83. Global Azithromycin Market Size, by Group, 2017-2032 (USD Million)
TABLE 84. Global Azithromycin Market Size, by Country, 2017-2032 (USD Million)
TABLE 85. Global Clarithromycin Market Size, by Region, 2017-2032 (USD Million)
TABLE 86. Global Clarithromycin Market Size, by Group, 2017-2032 (USD Million)
TABLE 87. Global Clarithromycin Market Size, by Country, 2017-2032 (USD Million)
TABLE 88. Global Erythromycin Market Size, by Region, 2017-2032 (USD Million)
TABLE 89. Global Erythromycin Market Size, by Group, 2017-2032 (USD Million)
TABLE 90. Global Erythromycin Market Size, by Country, 2017-2032 (USD Million)
TABLE 91. Global Gamithromycin Market Size, by Region, 2017-2032 (USD Million)
TABLE 92. Global Gamithromycin Market Size, by Group, 2017-2032 (USD Million)
TABLE 93. Global Gamithromycin Market Size, by Country, 2017-2032 (USD Million)
TABLE 94. Global Spiramycin Market Size, by Region, 2017-2032 (USD Million)
TABLE 95. Global Spiramycin Market Size, by Group, 2017-2032 (USD Million)
TABLE 96. Global Spiramycin Market Size, by Country, 2017-2032 (USD Million)
TABLE 97. Global Tilmicosin Market Size, by Region, 2017-2032 (USD Million)
TABLE 98. Global Tilmicosin Market Size, by Group, 2017-2032 (USD Million)
TABLE 99. Global Tilmicosin Market Size, by Country, 2017-2032 (USD Million)
TABLE 100. Global Tulathromycin Market Size, by Region, 2017-2032 (USD Million)
TABLE 101. Global Tulathromycin Market Size, by Group, 2017-2032 (USD Million)
TABLE 102. Global Tulathromycin Market Size, by Country, 2017-2032 (USD Million)
TABLE 103. Global Tylosin Market Size, by Region, 2017-2032 (USD Million)
TABLE 104. Global Tylosin Market Size, by Group, 2017-2032 (USD Million)
TABLE 105. Global Tylosin Market Size, by Country, 2017-2032 (USD Million)
TABLE 106. Global Other Quinolones Market Size, by Region, 2017-2032 (USD Million)
TABLE 107. Global Other Quinolones Market Size, by Group, 2017-2032 (USD Million)
TABLE 108. Global Other Quinolones Market Size, by Country, 2017-2032 (USD Million)
TABLE 109. Global Cinoxacin Market Size, by Region, 2017-2032 (USD Million)
TABLE 110. Global Cinoxacin Market Size, by Group, 2017-2032 (USD Million)
TABLE 111. Global Cinoxacin Market Size, by Country, 2017-2032 (USD Million)
TABLE 112. Global Nalidixic Acid Market Size, by Region, 2017-2032 (USD Million)
TABLE 113. Global Nalidixic Acid Market Size, by Group, 2017-2032 (USD Million)
TABLE 114. Global Nalidixic Acid Market Size, by Country, 2017-2032 (USD Million)
TABLE 115. Global Oxolinic Acid Market Size, by Region, 2017-2032 (USD Million)
TABLE 116. Global Oxolinic Acid Market Size, by Group, 2017-2032 (USD Million)
TABLE 117. Global Oxolinic Acid Market Size, by Country, 2017-2032 (USD Million)
TABLE 118. Global Pipemidic Acid Market Size, by Region, 2017-2032 (USD Million)
TABLE 119. Global Pipemidic Acid Market Size, by Group, 2017-2032 (USD Million)
TABLE 120. Global Pipemidic Acid Market Size, by Country, 2017-2032 (USD Million)
TABLE 121. Global Rosoxacin Market Size, by Region, 2017-2032 (USD Million)
TABLE 122. Global Rosoxacin Market Size, by Group, 2017-2032 (USD Million)
TABLE 123. Global Rosoxacin Market Size, by Country, 2017-2032 (USD Million)
TABLE 124. Global Penicillins Market Size, by Region, 2017-2032 (USD Million)
TABLE 125. Global Penicillins Market Size, by Group, 2017-2032 (USD Million)
TABLE 126. Global Penicillins Market Size, by Country, 2017-2032 (USD Million)
TABLE 127. Global Amoxicillin Market Size, by Region, 2017-2032 (USD Million)
TABLE 128. Global Amoxicillin Market Size, by Group, 2017-2032 (USD Million)
TABLE 129. Global Amoxicillin Market Size, by Country, 2017-2032 (USD Million)
TABLE 130. Global Ampicillin Market Size, by Region, 2017-2032 (USD Million)
TABLE 131. Global Ampicillin Market Size, by Group, 2017-2032 (USD Million)
TABLE 132. Global Ampicillin Market Size, by Country, 2017-2032 (USD Million)
TABLE 133. Global Cloxacillin Market Size, by Region, 2017-2032 (USD Million)
TABLE 134. Global Cloxacillin Market Size, by Group, 2017-2032 (USD Million)
TABLE 135. Global Cloxacillin Market Size, by Country, 2017-2032 (USD Million)
TABLE 136. Global Oxacillin Market Size, by Region, 2017-2032 (USD Million)
TABLE 137. Global Oxacillin Market Size, by Group, 2017-2032 (USD Million)
TABLE 138. Global Oxacillin Market Size, by Country, 2017-2032 (USD Million)
TABLE 139. Global Penicillin G Market Size, by Region, 2017-2032 (USD Million)
TABLE 140. Global Penicillin G Market Size, by Group, 2017-2032 (USD Million)
TABLE 141. Global Penicillin G Market Size, by Country, 2017-2032 (USD Million)
TABLE 142. Global Penicillin V Market Size, by Region, 2017-2032 (USD Million)
TABLE 143. Global Penicillin V Market Size, by Group, 2017-2032 (USD Million)
TABLE 144. Global Penicillin V Market Size, by Country, 2017-2032 (USD Million)
TABLE 145. Global Polymixins Market Size, by Region, 2017-2032 (USD Million)
TABLE 146. Global Polymixins Market Size, by Group, 2017-2032 (USD Million)
TABLE 147. Global Polymixins Market Size, by Country, 2017-2032 (USD Million)
TABLE 148. Global Colistin/Polymyxin E Market Size, by Region, 2017-2032 (USD Million)
TABLE 149. Global Colistin/Polymyxin E Market Size, by Group, 2017-2032 (USD Million)
TABLE 150. Global Colistin/Polymyxin E Market Size, by Country, 2017-2032 (USD Million)
TABLE 151. Global Polymyxin B Market Size, by Region, 2017-2032 (USD Million)
TABLE 152. Global Polymyxin B Market Size, by Group, 2017-2032 (USD Million)
TABLE 153. Global Polymyxin B Market Size, by Country, 2017-2032 (USD Million)
TABLE 154. Global Sulfonamides Market Size, by Region, 2017-2032 (USD Million)
TABLE 155. Global Sulfonamides Market Size, by Group, 2017-2032 (USD Million)
TABLE 156. Global Sulfonamides Market Size, by Country, 2017-2032 (USD Million)
TABLE 157. Global Sulfadiazine Market Size, by Region, 2017-2032 (USD Million)
TABLE 158. Global Sulfadiazine Market Size, by Group, 2017-2032 (USD Million)
TABLE 159. Global Sulfadiazine Market Size, by Country, 2017-2032 (USD Million)
TABLE 160. Global Sulfamerazine Market Size, by Region, 2017-2032 (USD Million)
TABLE 161. Global Sulfamerazine Market Size, by Group, 2017-2032 (USD Million)
TABLE 162. Global Sulfamerazine Market Size, by Country, 2017-2032 (USD Million)
TABLE 163. Global Sulfamethizole Market Size, by Region, 2017-2032 (USD Million)
TABLE 164. Global Sulfamethizole Market Size, by Group, 2017-2032 (USD Million)
TABLE 165. Global Sulfamethizole Market Size, by Country, 2017-2032 (USD Million)
TABLE 166. Global Sulfamethoxazole Market Size, by Region, 2017-2032 (USD Million)
TABLE 167. Global Sulfamethoxazole Market Size, by Group, 2017-2032 (USD Million)
TABLE 168. Global Sulfamethoxazole Market Size, by Country, 2017-2032 (USD Million)
TABLE 169. Global Sulfasalazine Market Size, by Region, 2017-2032 (USD Million)
TABLE 170. Global Sulfasalazine Market Size, by Group, 2017-2032 (USD Million)
TABLE 171. Global Sulfasalazine Market Size, by Country, 2017-2032 (USD Million)
TABLE 172. Global Tetracyclines Market Size, by Region, 2017-2032 (USD Million)
TABLE 173. Global Tetracyclines Market Size, by Group, 2017-2032 (USD Million)
TABLE 174. Global Tetracyclines Market Size, by Country, 2017-2032 (USD Million)
TABLE 175. Global Chlortetracycline Market Size, by Region, 2017-2032 (USD Million)
TABLE 176. Global Chlortetracycline Market Size, by Group, 2017-2032 (USD Million)
TABLE 177. Global Chlortetracycline Market Size, by Country, 2017-2032 (USD Million)
TABLE 178. Global Doxycycline Market Size, by Region, 2017-2032 (USD Million)
TABLE 179. Global Doxycycline Market Size, by Group, 2017-2032 (USD Million)
TABLE 180. Global Doxycycline Market Size, by Country, 2017-2032 (USD Million)
TABLE 181. Global Oxytetracycline Market Size, by Region, 2017-2032 (USD Million)
TABLE 182. Global Oxytetracycline Market Size, by Group, 2017-2032 (USD Million)
TABLE 183. Global Oxytetracycline Market Size, by Country, 2017-2032 (USD Million)
TABLE 184. Global Tetracycline Market Size, by Region, 2017-2032 (USD Million)
TABLE 185. Global Tetracycline Market Size, by Group, 2017-2032 (USD Million)
TABLE 186. Global Tetracycline Market Size, by Country, 2017-2032 (USD Million)
TABLE 187. Global Trimethoprim Market Size, by Region, 2017-2032 (USD Million)
TABLE 188. Global Trimethoprim Market Size, by Group, 2017-2032 (USD Million)
TABLE 189. Global Trimethoprim Market Size, by Country, 2017-2032 (USD Million)
TABLE 190. Global Trimethoprim Plus Sulfamethazine Market Size, by Region, 2017-2032 (USD Million)
TABLE 191. Global Trimethoprim Plus Sulfamethazine Market Size, by Group, 2017-2032 (USD Million)
TABLE 192. Global Trimethoprim Plus Sulfamethazine Market Size, by Country, 2017-2032 (USD Million)
TABLE 193. Global Trimethoprim-Sulfadiazine Market Size, by Region, 2017-2032 (USD Million)
TABLE 194. Global Trimethoprim-Sulfadiazine Market Size, by Group, 2017-2032 (USD Million)
TABLE 195. Global Trimethoprim-Sulfadiazine Market Size, by Country, 2017-2032 (USD Million)
TABLE 196. Global Trimethoprim-Sulfadimidine Market Size, by Region, 2017-2032 (USD Million)
TABLE 197. Global Trimethoprim-Sulfadimidine Market Size, by Group, 2017-2032 (USD Million)
TABLE 198. Global Trimethoprim-Sulfadimidine Market Size, by Country, 2017-2032 (USD Million)
TABLE 199. Global Trimethoprim-Sulfadoxine Market Size, by Region, 2017-2032 (USD Million)
TABLE 200. Global Trimethoprim-Sulfadoxine Market Size, by Group, 2017-2032 (USD Million)
TABLE 201. Global Trimethoprim-Sulfadoxine Market Size, by Country, 2017-2032 (USD Million)
TABLE 202. Global Trimethoprim-Sulfamethoxazole (TMP-SMX) Market Size, by Region, 2017-2032 (USD Million)
TABLE 203. Global Trimethoprim-Sulfamethoxazole (TMP-SMX) Market Size, by Group, 2017-2032 (USD Million)
TABLE 204. Global Trimethoprim-Sulfamethoxazole (TMP-SMX) Market Size, by Country, 2017-2032 (USD Million)
TABLE 205. Global Veterinary Antibiotics Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 206. Global Companion Animals Market Size, by Region, 2017-2032 (USD Million)
TABLE 207. Global Companion Animals Market Size, by Group, 2017-2032 (USD Million)
TABLE 208. Global Companion Animals Market Size, by Country, 2017-2032 (USD Million)
TABLE 209. Global Cats Market Size, by Region, 2017-2032 (USD Million)
TABLE 210. Global Cats Market Size, by Group, 2017-2032 (USD Million)
TABLE 211. Global Cats Market Size, by Country, 2017-2032 (USD Million)
TABLE 212. Global Dogs Market Size, by Region, 2017-2032 (USD Million)
TABLE 213. Global Dogs Market Size, by Group, 2017-2032 (USD Million)
TABLE 214. Global Dogs Market Size, by Country, 2017-2032 (USD Million)
TABLE 215. Global Livestock Market Size, by Region, 2017-2032 (USD Million)
TABLE 216. Global Livestock Market Size, by Group, 2017-2032 (USD Million)
TABLE 217. Global Livestock Market Size, by Country, 2017-2032 (USD Million)
TABLE 218. Global Cattle Market Size, by Region, 2017-2032 (USD Million)
TABLE 219. Global Cattle Market Size, by Group, 2017-2032 (USD Million)
TABLE 220. Global Cattle Market Size, by Country, 2017-2032 (USD Million)
TABLE 221. Global Poultry Market Size, by Region, 2017-2032 (USD Million)
TABLE 222. Global Poultry Market Size, by Group, 2017-2032 (USD Million)
TABLE 223. Global Poultry Market Size, by Country, 2017-2032 (USD Million)
TABLE 224. Global Sheep & Goats Market Size, by Region, 2017-2032 (USD Million)
TABLE 225. Global Sheep & Goats Market Size, by Group, 2017-2032 (USD Million)
TABLE 226. Global Sheep & Goats Market Size, by Country, 2017-2032 (USD Million)
TABLE 227. Global Swine Market Size, by Region, 2017-2032 (USD Million)
TABLE 228. Global Swine Market Size, by Group, 2017-2032 (USD Million)
TABLE 229. Global Swine Market Size, by Country, 2017-2032 (USD Million)
TABLE 230. Global Veterinary Antibiotics Market Size, by End-User, 2017-2032 (USD Million)
TABLE 231. Global Animal Production Facilities Market Size, by Region, 2017-2032 (USD Million)
TABLE 232. Global Animal Production Facilities Market Size, by Group, 2017-2032 (USD Million)
TABLE 233. Global Animal Production Facilities Market Size, by Country, 2017-2032 (USD Million)
TABLE 234. Global Household Pet Owners Market Size, by Region, 2017-2032 (USD Million)
TABLE 235. Global Household Pet Owners Market Size, by Group, 2017-2032 (USD Million)
TABLE 236. Global Household Pet Owners Market Size, by Country, 2017-2032 (USD Million)
TABLE 237. Global Veterinary Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 238. Global Veterinary Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 239. Global Veterinary Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 240. Global Veterinary Antibiotics Market Size, by Therapeutic Areas, 2017-2032 (USD Million)
TABLE 241. Global Dermatological Infections Market Size, by Region, 2017-2032 (USD Million)
TABLE 242. Global Dermatological Infections Market Size, by Group, 2017-2032 (USD Million)
TABLE 243. Global Dermatological Infections Market Size, by Country, 2017-2032 (USD Million)
TABLE 244. Global Gastrointestinal Infections Market Size, by Region, 2017-2032 (USD Million)
TABLE 245. Global Gastrointestinal Infections Market Size, by Group, 2017-2032 (USD Million)
TABLE 246. Global Gastrointestinal Infections Market Size, by Country, 2017-2032 (USD Million)
TABLE 247. Global Reproductive System Infections Market Size, by Region, 2017-2032 (USD Million)
TABLE 248. Global Reproductive System Infections Market Size, by Group, 2017-2032 (USD Million)
TABLE 249. Global Reproductive System Infections Market Size, by Country, 2017-2032 (USD Million)
TABLE 250. Global Respiratory Infections Market Size, by Region, 2017-2032 (USD Million)
TABLE 251. Global Respiratory Infections Market Size, by Group, 2017-2032 (USD Million)
TABLE 252. Global Respiratory Infections Market Size, by Country, 2017-2032 (USD Million)
TABLE 253. Global Soft Tissue & Wound Infections Market Size, by Region, 2017-2032 (USD Million)
TABLE 254. Global Soft Tissue & Wound Infections Market Size, by Group, 2017-2032 (USD Million)
TABLE 255. Global Soft Tissue & Wound Infections Market Size, by Country, 2017-2032 (USD Million)
TABLE 256. Global Systemic Infections Market Size, by Region, 2017-2032 (USD Million)
TABLE 257. Global Systemic Infections Market Size, by Group, 2017-2032 (USD Million)
TABLE 258. Global Systemic Infections Market Size, by Country, 2017-2032 (USD Million)
TABLE 259. Global Urinary Tract Infections Market Size, by Region, 2017-2032 (USD Million)
TABLE 260. Global Urinary Tract Infections Market Size, by Group, 2017-2032 (USD Million)
TABLE 261. Global Urinary Tract Infections Market Size, by Country, 2017-2032 (USD Million)
TABLE 262. Global Veterinary Antibiotics Market Size, by Region, 2017-2032 (USD Million)
TABLE 263. Asia-Pacific Veterinary Antibiotics Market Size, by Region, 2017-2032 (USD Million)
TABLE 264. Asia-Pacific Veterinary Antibiotics Market Size, by Class, 2017-2032 (USD Million)
TABLE 265. Asia-Pacific Veterinary Antibiotics Market Size, by Aminoglycosides, 2017-2032 (USD Million)
TABLE 266. Asia-Pacific Veterinary Antibiotics Market Size, by Amphenicols, 2017-2032 (USD Million)
TABLE 267. Asia-Pacific Veterinary Antibiotics Market Size, by Cephalosporins, 2017-2032 (USD Million)
TABLE 268. Asia-Pacific Veterinary Antibiotics Market Size, by Fluoroquinolones, 2017-2032 (USD Million)
TABLE 269. Asia-Pacific Veterinary Antibiotics Market Size, by Macrolides, 2017-2032 (USD Million)
TABLE 270. Asia-Pacific Veterinary Antibiotics Market Size, by Other Quinolones, 2017-2032 (USD Million)
TABLE 271. Asia-Pacific Veterinary Antibiotics Market Size, by Penicillins, 2017-2032 (USD Million)
TABLE 272. Asia-Pacific Veterinary Antibiotics Market Size, by Polymixins, 2017-2032 (USD Million)
TABLE 273. Asia-Pacific Veterinary Antibiotics Market Size, by Sulfonamides, 2017-2032 (USD Million)
TABLE 274. Asia-Pacific Veterinary Antibiotics Market Size, by Tetracyclines, 2017-2032 (USD Million)
TABLE 275. Asia-Pacific Veterinary Antibiotics Market Size, by Trimethoprim, 2017-2032 (USD Million)
TABLE 276. Asia-Pacific Veterinary Antibiotics Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 277. Asia-Pacific Veterinary Antibiotics Market Size, by Companion Animals, 2017-2032 (USD Million)
TABLE 278. Asia-Pacific Veterinary Antibiotics Market Size, by Livestock, 2017-2032 (USD Million)
TABLE 279. Asia-Pacific Veterinary Antibiotics Market Size, by End-User, 2017-2032 (USD Million)
TABLE 280. Asia-Pacific Veterinary Antibiotics Market Size, by Therapeutic Areas, 2017-2032 (USD Million)
TABLE 281. North America Veterinary Antibiotics Market Size, by Region, 2017-2032 (USD Million)
TABLE 282. North America Veterinary Antibiotics Market Size, by Class, 2017-2032 (USD Million)
TABLE 283. North America Veterinary Antibiotics Market Size, by Aminoglycosides, 2017-2032 (USD Million)
TABLE 284. North America Veterinary Antibiotics Market Size, by Amphenicols, 2017-2032 (USD Million)
TABLE 285. North America Veterinary Antibiotics Market Size, by Cephalosporins, 2017-2032 (USD Million)
TABLE 286. North America Veterinary Antibiotics Market Size, by Fluoroquinolones, 2017-2032 (USD Million)
TABLE 287. North America Veterinary Antibiotics Market Size, by Macrolides, 2017-2032 (USD Million)
TABLE 288. North America Veterinary Antibiotics Market Size, by Other Quinolones, 2017-2032 (USD Million)
TABLE 289. North America Veterinary Antibiotics Market Size, by Penicillins, 2017-2032 (USD Million)
TABLE 290. North America Veterinary Antibiotics Market Size, by Polymixins, 2017-2032 (USD Million)
TABLE 291. North America Veterinary Antibiotics Market Size, by Sulfonamides, 2017-2032 (USD Million)
TABLE 292. North America Veterinary Antibiotics Market Size, by Tetracyclines, 2017-2032 (USD Million)
TABLE 293. North America Veterinary Antibiotics Market Size, by Trimethoprim, 2017-2032 (USD Million)
TABLE 294. North America Veterinary Antibiotics Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 295. North America Veterinary Antibiotics Market Size, by Companion Animals, 2017-2032 (USD Million)
TABLE 296. North America Veterinary Antibiotics Market Size, by Livestock, 2017-2032 (USD Million)
TABLE 297. North America Veterinary Antibiotics Market Size, by End-User, 2017-2032 (USD Million)
TABLE 298. North America Veterinary Antibiotics Market Size, by Therapeutic Areas, 2017-2032 (USD Million)
TABLE 299. Latin America Veterinary Antibiotics Market Size, by Region, 2017-2032 (USD Million)
TABLE 300. Latin America Veterinary Antibiotics Market Size, by Class, 2017-2032 (USD Million)
TABLE 301. Latin America Veterinary Antibiotics Market Size, by Aminoglycosides, 2017-2032 (USD Million)
TABLE 302. Latin America Veterinary Antibiotics Market Size, by Amphenicols, 2017-2032 (USD Million)
TABLE 303. Latin America Veterinary Antibiotics Market Size, by Cephalosporins, 2017-2032 (USD Million)
TABLE 304. Latin America Veterinary Antibiotics Market Size, by Fluoroquinolones, 2017-2032 (USD Million)
TABLE 305. Latin America Veterinary Antibiotics Market Size, by Macrolides, 2017-2032 (USD Million)
TABLE 306. Latin America Veterinary Antibiotics Market Size, by Other Quinolones, 2017-2032 (USD Million)
TABLE 307. Latin America Veterinary Antibiotics Market Size, by Penicillins, 2017-2032 (USD Million)
TABLE 308. Latin America Veterinary Antibiotics Market Size, by Polymixins, 2017-2032 (USD Million)
TABLE 309. Latin America Veterinary Antibiotics Market Size, by Sulfonamides, 2017-2032 (USD Million)
TABLE 310. Latin America Veterinary Antibiotics Market Size, by Tetracyclines, 2017-2032 (USD Million)
TABLE 311. Latin America Veterinary Antibiotics Market Size, by Trimethoprim, 2017-2032 (USD Million)
TABLE 312. Latin America Veterinary Antibiotics Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 313. Latin America Veterinary Antibiotics Market Size, by Companion Animals, 2017-2032 (USD Million)
TABLE 314. Latin America Veterinary Antibiotics Market Size, by Livestock, 2017-2032 (USD Million)
TABLE 315. Latin America Veterinary Antibiotics Market Size, by End-User, 2017-2032 (USD Million)
TABLE 316. Latin America Veterinary Antibiotics Market Size, by Therapeutic Areas, 2017-2032 (USD Million)
TABLE 317. Europe Veterinary Antibiotics Market Size, by Region, 2017-2032 (USD Million)
TABLE 318. Europe Veterinary Antibiotics Market Size, by Class, 2017-2032 (USD Million)
TABLE 319. Europe Veterinary Antibiotics Market Size, by Aminoglycosides, 2017-2032 (USD Million)
TABLE 320. Europe Veterinary Antibiotics Market Size, by Amphenicols, 2017-2032 (USD Million)
TABLE 321. Europe Veterinary Antibiotics Market Size, by Cephalosporins, 2017-2032 (USD Million)
TABLE 322. Europe Veterinary Antibiotics Market Size, by Fluoroquinolones, 2017-2032 (USD Million)
TABLE 323. Europe Veterinary Antibiotics Market Size, by Macrolides, 2017-2032 (USD Million)
TABLE 324. Europe Veterinary Antibiotics Market Size, by Other Quinolones, 2017-2032 (USD Million)
TABLE 325. Europe Veterinary Antibiotics Market Size, by Penicillins, 2017-2032 (USD Million)
TABLE 326. Europe Veterinary Antibiotics Market Size, by Polymixins, 2017-2032 (USD Million)
TABLE 327. Europe Veterinary Antibiotics Market Size, by Sulfonamides, 2017-2032 (USD Million)
TABLE 328. Europe Veterinary Antibiotics Market Size, by Tetracyclines, 2017-2032 (USD Million)
TABLE 329. Europe Veterinary Antibiotics Market Size, by Trimethoprim, 2017-2032 (USD Million)
TABLE 330. Europe Veterinary Antibiotics Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 331. Europe Veterinary Antibiotics Market Size, by Companion Animals, 2017-2032 (USD Million)
TABLE 332. Europe Veterinary Antibiotics Market Size, by Livestock, 2017-2032 (USD Million)
TABLE 333. Europe Veterinary Antibiotics Market Size, by End-User, 2017-2032 (USD Million)
TABLE 334. Europe Veterinary Antibiotics Market Size, by Therapeutic Areas, 2017-2032 (USD Million)
TABLE 335. Middle East Veterinary Antibiotics Market Size, by Region, 2017-2032 (USD Million)
TABLE 336. Middle East Veterinary Antibiotics Market Size, by Class, 2017-2032 (USD Million)
TABLE 337. Middle East Veterinary Antibiotics Market Size, by Aminoglycosides, 2017-2032 (USD Million)
TABLE 338. Middle East Veterinary Antibiotics Market Size, by Amphenicols, 2017-2032 (USD Million)
TABLE 339. Middle East Veterinary Antibiotics Market Size, by Cephalosporins, 2017-2032 (USD Million)
TABLE 340. Middle East Veterinary Antibiotics Market Size, by Fluoroquinolones, 2017-2032 (USD Million)
TABLE 341. Middle East Veterinary Antibiotics Market Size, by Macrolides, 2017-2032 (USD Million)
TABLE 342. Middle East Veterinary Antibiotics Market Size, by Other Quinolones, 2017-2032 (USD Million)
TABLE 343. Middle East Veterinary Antibiotics Market Size, by Penicillins, 2017-2032 (USD Million)
TABLE 344. Middle East Veterinary Antibiotics Market Size, by Polymixins, 2017-2032 (USD Million)
TABLE 345. Middle East Veterinary Antibiotics Market Size, by Sulfonamides, 2017-2032 (USD Million)
TABLE 346. Middle East Veterinary Antibiotics Market Size, by Tetracyclines, 2017-2032 (USD Million)
TABLE 347. Middle East Veterinary Antibiotics Market Size, by Trimethoprim, 2017-2032 (USD Million)
TABLE 348. Middle East Veterinary Antibiotics Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 349. Middle East Veterinary Antibiotics Market Size, by Companion Animals, 2017-2032 (USD Million)
TABLE 350. Middle East Veterinary Antibiotics Market Size, by Livestock, 2017-2032 (USD Million)
TABLE 351. Middle East Veterinary Antibiotics Market Size, by End-User, 2017-2032 (USD Million)
TABLE 352. Middle East Veterinary Antibiotics Market Size, by Therapeutic Areas, 2017-2032 (USD Million)
TABLE 353. Africa Veterinary Antibiotics Market Size, by Region, 2017-2032 (USD Million)
TABLE 354. Africa Veterinary Antibiotics Market Size, by Class, 2017-2032 (USD Million)
TABLE 355. Africa Veterinary Antibiotics Market Size, by Aminoglycosides, 2017-2032 (USD Million)
TABLE 356. Africa Veterinary Antibiotics Market Size, by Amphenicols, 2017-2032 (USD Million)
TABLE 357. Africa Veterinary Antibiotics Market Size, by Cephalosporins, 2017-2032 (USD Million)
TABLE 358. Africa Veterinary Antibiotics Market Size, by Fluoroquinolones, 2017-2032 (USD Million)
TABLE 359. Africa Veterinary Antibiotics Market Size, by Macrolides, 2017-2032 (USD Million)
TABLE 360. Africa Veterinary Antibiotics Market Size, by Other Quinolones, 2017-2032 (USD Million)
TABLE 361. Africa Veterinary Antibiotics Market Size, by Penicillins, 2017-2032 (USD Million)
TABLE 362. Africa Veterinary Antibiotics Market Size, by Polymixins, 2017-2032 (USD Million)
TABLE 363. Africa Veterinary Antibiotics Market Size, by Sulfonamides, 2017-2032 (USD Million)
TABLE 364. Africa Veterinary Antibiotics Market Size, by Tetracyclines, 2017-2032 (USD Million)
TABLE 365. Africa Veterinary Antibiotics Market Size, by Trimethoprim, 2017-2032 (USD Million)
TABLE 366. Africa Veterinary Antibiotics Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 367. Africa Veterinary Antibiotics Market Size, by Companion Animals, 2017-2032 (USD Million)
TABLE 368. Africa Veterinary Antibiotics Market Size, by Livestock, 2017-2032 (USD Million)
TABLE 369. Africa Veterinary Antibiotics Market Size, by End-User, 2017-2032 (USD Million)
TABLE 370. Africa Veterinary Antibiotics Market Size, by Therapeutic Areas, 2017-2032 (USD Million)
TABLE 371. Global Veterinary Antibiotics Market Size, by Group, 2017-2032 (USD Million)
TABLE 372. ASEAN Veterinary Antibiotics Market Size, by Group, 2017-2032 (USD Million)
TABLE 373. ASEAN Veterinary Antibiotics Market Size, by Class, 2017-2032 (USD Million)
TABLE 374. ASEAN Veterinary Antibiotics Market Size, by Aminoglycosides, 2017-2032 (USD Million)
TABLE 375. ASEAN Veterinary Antibiotics Market Size, by Amphenicols, 2017-2032 (USD Million)
TABLE 376. ASEAN Veterinary Antibiotics Market Size, by Cephalosporins, 2017-2032 (USD Million)
TABLE 377. ASEAN Veterinary Antibiotics Market Size, by Fluoroquinolones, 2017-2032 (USD Million)
TABLE 378. ASEAN Veterinary Antibiotics Market Size, by Macrolides, 2017-2032 (USD Million)
TABLE 379. ASEAN Veterinary Antibiotics Market Size, by Other Quinolones, 2017-2032 (USD Million)
TABLE 380. ASEAN Veterinary Antibiotics Market Size, by Penicillins, 2017-2032 (USD Million)
TABLE

Companies Mentioned

  • Ashish Life Science Private Limited
  • Bimeda Inc.
  • Biogénesis Bagó S.A.
  • C.H. Boehringer Sohn AG & Co. KG
  • Ceva Santé Animale
  • Dechra Pharmaceuticals PLC
  • Eco Animal Health Group PLC
  • Elanco Animal Health Incorporated
  • Intas Pharmaceuticals Ltd.
  • Krka, d. d., Novo mesto
  • Kyoritsuseiyaku Corporation
  • LABORATORIO AVI-MEX
  • LABORATORIOS CALIER, S.A.
  • Merck KGaA
  • Neogen Corporation
  • Ourofino Group
  • Sequent Scientific Ltd.
  • Vetoquinol SA
  • Virbac SA
  • Zoetis Inc.

Related Topics

Related Reports

Veterinary Antibiotics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Veterinary Antibiotics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 180 Pages
  • Global
From
Veterinary Antibiotics Market Outlook 2026-2034: Market Share, and Growth Analysis by Animal Type (Poultry, Swine, Cattle, Sheep & Goats, Companion Animals, Aquaculture, Other Livestock), Drug Class, Delivery Form, Spectrum of Activity - Product Image

Veterinary Antibiotics Market Outlook 2026-2034: Market Share, and Growth Analysis by Animal Type (Poultry, Swine, Cattle, Sheep & Goats, Companion Animals, Aquaculture, Other Livestock), Drug Class, Delivery Form, Spectrum of Activity

  • Report
  • 160 Pages
  • Global
From
Veterinary Antibiotics Market Report 2026 - Product Image

Veterinary Antibiotics Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Animal Antibiotics & Antimicrobials Market - Global Forecast 2026-2032 - Product Image

Animal Antibiotics & Antimicrobials Market - Global Forecast 2026-2032

  • Report
  • 180 Pages
  • Global
From
Non-Therapeutic Antibiotics for Food Animals Market - Global Forecast 2026-2032 - Product Image

Non-Therapeutic Antibiotics for Food Animals Market - Global Forecast 2026-2032

  • Report
  • 185 Pages
  • Global
From

About the Veterinary Antibiotics Market

The Veterinary Antibiotics market is a segment of the Animal Healthcare/Veterinary industry that focuses on the production and distribution of antibiotics for use in animals. Veterinary antibiotics are used to treat a variety of bacterial infections in animals, including respiratory, gastrointestinal, and urinary tract infections. They are also used to prevent and control the spread of infectious diseases in animals. Veterinary antibiotics are available in a variety of forms, including tablets, capsules, liquids, and injectables. Veterinary antibiotics are regulated by the Food and Drug Administration (FDA) and must meet certain safety and efficacy standards. Veterinary antibiotics are typically prescribed by veterinarians and dispensed by pharmacies. In some cases, they may be available over-the-counter. Some companies in the Veterinary Antibiotics market include Bayer, Merck, Zoetis, Elanco, and Boehringer Ingelheim. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.